Evidence map›Paper›PMID 22516618›Full record

ReviewTrends in neurosciences2012

EphBs: an integral link between synaptic function and synaptopathies.

Sean I Sheffler-Collins, Matthew B Dalva

Open access · greenAbstract readReview
In one paragraph

Review in Trends in neurosciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. EphB2 Signaling Is Implicated in Astrocyte-Mediated Parvalbumin Inhibitory Synapse Development.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Alzheimer's Disease and Protein Kinases.Advances in experimental medicine and biology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sean I Sheffler-CollinsDepartment of Neuroscience and Farber Institute for Neurosciences, Thomas Jefferson University, 900 Walnut Street, Suite 462, Philadelphia, PA 19107, USA.
Matthew B Dalva
Thomas Jefferson University · US

Funding

Cell-Contact Mediated Mechanisms Assembling Synapses (R01DA022727)R01DA022727 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DALVA, MATTHEW B · 2007 to 2025
$5.2M
RESEARCH ON NORMAL AND ABNORMAL MECHANISMS OF VISIONST32EY007035 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Diego Contreras, Jessica I.W. Morgan · 1985 to 2026
$4.9M
Genetic indicators for imaging of cell signaling in plasticity and developmentR01MH086425 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI DALVA, MATTHEW B · 2009 to 2013
$1.9M
NEI NIH HHS EY007035NEI NIH HHS T32 EY007035NIDA NIH HHS DA022727NIDA NIH HHS R01 DA022727NIMH NIH HHS MH086425NIMH NIH HHS R01 MH086425
6 · The paper itself

Abstract

The assembly and function of neuronal circuits rely on selective cell-cell interactions to control axon targeting, generate pre- and postsynaptic specialization and recruit neurotransmitter receptors. In neurons, EphB receptor tyrosine kinases mediate excitatory synaptogenesis early during development, and then later coordinate synaptic function by controlling synaptic glutamate receptor localization and function. EphBs direct synapse formation and function to regulate cellular morphology through downstream signaling mechanisms and by interacting with glutamate receptors. In humans, defective EphB-dependent regulation of NMDA receptor (NMDAR) localization and function is associated with neurological disorders, including neuropathic pain, anxiety disorders and Alzheimer's disease (AD). Here, we propose that EphBs act as a central organizer of excitatory synapse formation and function, and as a key regulator of diseases linked to NMDAR dysfunction.

Indexed as

Alzheimer DiseaseAnimalsAnxietyBrainHumansNeuralgiaNeurogenesisReceptors, Eph FamilySynapsesReceptors, Eph Family

Identifiers

PMID22516618
PMCPMC3631563
OpenAlexW2011848026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.